Facebook Pixel "The ecosystem of Gujarat is ready to promote deep tech areas of biotech product development" | Bio Spectrum - business - Read this story on Magzter.com

Try GOLD - Free

"The ecosystem of Gujarat is ready to promote deep tech areas of biotech product development"

Bio Spectrum

|

BioSpectrum Indian Feb 2025

ujarat has more than 200 biotechnology Gamers and a thriving startup ecosystem that includes prominent R&D and educational institutes. Gujarat's biotech sector generates more than Rs 12000 crore revenue and serves as an established biomanufacturing hub. Playing a key role in this direction is the Gujarat State Biotechnology Mission GSBTM) which has completed 20 years. The Government of Gujarat GoG) had established GSBTM in April 2004 under the Department of Science and Technology to facilitate the development of the biotech sector. In conversation with BioSpectrum, Manish Gurwani, Mission Director, Gujarat State Biotechnology Mission elaborates on how GSBTM’s latest biotechnology policy is transforming the sector in Gujarat. Edited excerpts:

- Ankit Kankar

"The ecosystem of Gujarat is ready to promote deep tech areas of biotech product development"

How does the GSBTM plan to leverage infrastructure and incentives under the current policy to position the state as a globally competitive biotechnology hub?

Known for its entrepreneurship spirit, Gujarat has continued to be one of the preferred investment destinations for Ease of Doing Business (EoDB), Good Governance Index (GGI), Energy & Climate Index, Startup & LEADS ranking. The state contributes 40 per cent to India’s total cargo throughput with ~8.2 per cent in India’s GDP (as on FY2022-23 on current price). The state accounts for $12 billion (2023) with 8 per cent share of Bioeconomy, way above ~4 per cent state-wise average contribution of Bio-economy, amongst top 5 states of India in terms of Bio-economy contributors. This is the result of its top-class trunk and core infrastructure coupled with a safe and sound social environment in attracting top entrepreneurs from various parts of the country and abroad.

Gujarat showed great foresight, by setting up a dedicated mission office two decades ago, the Gujarat State Biotechnology Mission (GSBTM) followed by eco-system strengthening initiatives like Gujarat Biotechnology Research Centre (GBRC), Gujarat Biotechnology University (GBU) – Asia’s first ever dedicated biotechnology university and one of the top 5 public incubators Savli Technology and Business Incubator (STBI) with dedicated biotechnology parks for greenfield and brownfield spaces. These initiatives indicate Gujarat’s readiness to attract top biotech players in one of the thriving biotech ecosystems. GSBTM not only operates different schemes for facilitation of biotechnology, but is also the single window clearance office for all purposes, bringing in ease of doing business.

MORE STORIES FROM Bio Spectrum

Bio Spectrum

Bio Spectrum

MAHE teams up with OpenAI to integrate AI to enhance outcomes

Manipal Academy of Higher Education (MAHE), an Institution of Eminence Deemed to be University in Karnataka, has partnered with OpenAI to integrate advanced artificial intelligence (AI) tools across teaching, research, and academic administration.

time to read

1 min

April 2026

Bio Spectrum

Bio Spectrum

Jubilant Bhartia Foundation & McGill University to launch CoE in AI education

The Jubilant Bhartia Foundation in collaboration with McGill University (Canada), has signed a Memorandum of Understanding (MoU) to create the Centre of Excellence (CoE) in artificial intelligence (AI) Education and Research.

time to read

1 min

April 2026

Bio Spectrum

Bio Spectrum

Heeding Auditory Warning Signs

By 2050, nearly 2.5 billion people are projected to have some degree of hearing loss, and more than 700 million might require hearing rehabilitation. That's according to the World Health Organization (WHO).

time to read

2 mins

April 2026

Bio Spectrum

Bio Spectrum

Botanic Healthcare on-boards Narahari Naidu as Group Chief Financial Officer

Secundarabad-based Botanic Healthcare, a globally leading nutraceutical company, has announced the appointment of Narahari Naidu as its Group Chief Financial Officer (CFO).

time to read

1 min

April 2026

Bio Spectrum

Bio Spectrum

Paras Health ropes in Balkishan Sharma as Group CHRO and Business Transformation Officer

Paras Health has announced the appointment of Balkishan Sharma as Group Chief Human Resources Officer (Group CHRO) and Business Transformation Officer.

time to read

1 min

April 2026

Bio Spectrum

Bio Spectrum

Parse Biosciences unveils Evercode Whole Transcriptome V4 with shorter workflow

Parse Biosciences, a Qiagen company, has announced the launch of the new Evercode Whole Transcriptome v4 product line, delivering expanded scalability, higher sensitivity and a simplified workflow for single-cell RNA sequencing. Evercode v4 supports extraordinary scalability of up to five million cells and 384 samples in a single run, enabling researchers

time to read

1 min

April 2026

Bio Spectrum

Bio Spectrum

UK deploys new bone scanners to help prevent fractures

Tens of thousands of patients at risk of osteoporosis and other bone conditions will get faster access to vital bone scans, as 20 new scanners are rolled out across England.

time to read

1 min

April 2026

Bio Spectrum

Bio Spectrum

Cytiva expands Fast Trak process development and validation services facility in India

Cytiva, a Danaher company and a leader in the life sciences industry, has inaugurated an expanded facility for Fast Trak process development (PD) and validation services in Bengaluru.

time to read

1 min

April 2026

Bio Spectrum

Bio Spectrum

ΑΙ TAKES INDIAN PHARMA REINS

The Indian pharmaceutical sector, one of the largest in the world, is undergoing a strategic transformation in the way it operates. As artificial intelligence (AI) gains prominence across the industry, companies are actively adopting Al-driven solutions to enhance efficiency across the entire pharmaceutical ecosystem. Organisations are investing in AI training programmes to keep their workforce future-ready, foster innovation, strengthen supply chains, and transition away from manual record-keeping. In this industry analysis, experts share their perspectives on how AI is shaping the future of the pharma sector.

time to read

10 mins

April 2026

Bio Spectrum

NIH halts arm of clinical trial evaluating potential stroke treatment

The National Institutes of Health (NIH) in the US has stopped an investigational treatment arm of the Comparison of Anti-coagulation and Anti-platelet Therapies for Intracranial Vascular Atherostenosis (CAPTIVA) study, following a regular review by the Data Safety and Monitoring Board (DSMB).

time to read

1 min

April 2026

Listen

Translate

Share

-
+

Change font size